90721-58-7

Basic information

• Product Name: Methyl 2-broMo-5-(broMoMethyl)benzoate
• Synonyms: Methyl 2-broMo-5-(broMoMethyl)benzoate;Methyl 2-bromo-5-(bromomethyl);2-bromo-5-(bromomethyl)benzoate;2-Bromo-5-bromomethyl-benzoic acid methyl ester
• CAS NO: 90721-58-7
• Molecular Formula: C₉H₈Br₂O₂
• Molecular Weight: 307.96662
• Mol File: 90721-58-7.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: Methyl 2-broMo-5-(broMoMethyl)benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 2-broMo-5-(broMoMethyl)benzoate(90721-58-7)
• EPA Substance Registry System: Methyl 2-broMo-5-(broMoMethyl)benzoate(90721-58-7)

Safety Data

• Hazardous Substances Data: 90721-58-7(Hazardous Substances Data)

Usage

General Description

Methyl 2-bromo-5-(bromomethyl)benzoate is a chemical compound with the molecular formula C9H8Br2O2. It is a white to light yellow solid with a molecular weight of 291.97 g/mol. Methyl 2-broMo-5-(broMoMethyl)benzoate is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. It is also utilized in organic synthesis as a reagent for various chemical reactions. Methyl 2-bromo-5-(bromomethyl)benzoate has potential applications in the field of medicinal chemistry and drug development due to its versatile chemical properties. Additionally, it is important to handle and store this compound with proper safety measures, as it is hazardous if not used or handled correctly.

Upstream product

• 90971-88-3 methyl 2-bromo-5-methylbenzoate 

Downstream Products

• 1239957-13-1 amino(3-(2-carboxy-4-((5-(2-(3,4-dichlorophenyl)propan-2-yl)-1-(4-fluoro-3-methoxyphenyl)-1H-imidazol-2-ylthio)methyl)phenyl)propylamino)methaniminium 2,2,2-trifluoroacetate 
• 1239963-54-2 methyl 5-((5-(2-(3,4-dichlorophenyl)propan-2-yl)-1-(4-fluoro-3-methoxyphenyl)-1H-imidazol-2-ylthio)methyl)-2-(3-guanidinopropyl)benzoate 
• 1239957-07-3 methyl 5-((5-(2-(3,4-dichlorophenyl)propan-2-yl)-1-(4-fluoro-3-methoxyphenyl)-1H-imidazol-2-ylthio)methyl)-2-(3-hydroxypropyl)benzoate 
• 1239963-49-5 methyl 5-((5-(2-(3,4-dichlorophenyl)propan-2-yl)-1-(4-fluoro-3-methoxyphenyl)-1H-imidazol-2-ylthio)methyl)-2-(3-hydroxyprop-1-ynyl)benzoate 
• 1261638-98-5 C₂₃H₂₂BrNO₅S 
• 1239956-64-9 methyl 2-bromo-5-((5-(2-(3,4-dichlorophenyl)propan-2-yl)-1-(4-fluoro-3-methoxyphenyl)-1H-imidazol-2-ylthio)methyl)benzoate 
• 1187238-21-6 2-bromo-5-(hydroxymethyl)benzoic acid 

Relevant articles and documents

Identification and structure–activity relationship exploration of uracil-based benzoic acid and ester derivatives as novel dipeptidyl Peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus

Our previously reported carboxyl-containing DPP-4 inhibitors were highly potent but were poorly bioavailable. Esters of the carboxyl analogs exhibited a significant DPP-4 potency loss albeit with enhanced oral absorption. Herein, we described identificati

RENIN INHIBITORS

The present invention relates to biphenyl compounds of formula (I). These compounds are renin inhibitors of a non- peptidic nature and of low molecular weight. The invention further relates to a pharmaceutical composition containing said compounds, as wel

Pyrimidin derivatives

The invention relates to new pharmaceutically active compounds which are are P2-purinoceptor 7-transmembrane (TM) G-protein coupled receptor antagonists, compositions containing them and processes for their preparation.